Company / Depreciation & Amortization
LIFECORE BIOMEDICAL, INC. \DE\ Depreciation & Amortization History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$10.7M
FY2019
5-year range
$7.1M / $10.7M
FY2015-FY2019
Trend
+13.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $7M to $11M over the past 2 years.
Based on SEC 10-K filings.
$11M in FY2019 with a 5-year CAGR of +13.7%.
Increased from $7M to $11M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.7%, indicating consistent growth.
- In FY2019, depreciation & amortization increased 13.6% year-over-year.
- Lowest depreciation & amortization in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $10.7M | +13.6% |
| FY2018 | $9.4M | +32.5% |
| FY2017 | $7.1M | -0.3% |
| FY2016 | $7.1M | -2.5% |
| FY2015 | $7.3M | +29.8% |
| FY2014 | $5.6M | +5.8% |
| FY2013 | $5.3M | +57.9% |
| FY2012 | $3.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026